Jade Biosciences, Inc.
Pharmaceutical company · Waltham, Massachusetts, United States · Nasdaq: JBIO
Jade Biosciences, Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker JBIO. It has reported private securities offerings to the US SEC, most recently $76 million sold in a notice filed in 2020.
Jade Biosciences at a glance
What does Jade Biosciences do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $75.8 million sold (2020).
Frequently asked questions about Jade Biosciences
Where is Jade Biosciences headquartered?
Jade Biosciences, Inc. is headquartered in Waltham, Massachusetts, United States.
What does Jade Biosciences do?
Jade Biosciences, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Jade Biosciences a public company?
Yes. Jade Biosciences, Inc. trades on Nasdaq under the ticker JBIO.
When was Jade Biosciences founded?
The earliest incorporation on record for Jade Biosciences, Inc. is in 2018, according to public company registers.
Similar companies
- Mustang Bio, Inc.Waltham, Massachusetts, United States
- Alkermes IncWaltham, Massachusetts, United States
- Spyre Therapeutics, Inc.Waltham, Massachusetts, United States
- Cogent Biosciences, Inc.Waltham, Massachusetts, United States
- Viridian Therapeutics, Inc.\DEWaltham, Massachusetts, United States
- Dyne Therapeutics, Inc.Waltham, Massachusetts, United States
- Korsana Biosciences, Inc.Waltham, Massachusetts, United States
- Werewolf Therapeutics, Inc.Waltham, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.